Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;85:870-871

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beckman, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckman, J. S.
Related Collections
Right arrow Apoptosis
Right arrow Growth factors/cytokines
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 1999;85:870-871.)
© 1999 American Heart Association, Inc.


Editorials

Parsing the Effects of Nitric Oxide, S-Nitrosothiols, and Peroxynitrite on Inducible Nitric Oxide Synthase–Dependent Cardiac Myocyte Apoptosis

Joseph S. Beckman

From the Department of Anesthesiology, University of Alabama at Birmingham.

Correspondence to Joseph S. Beckman, PhD, Department of Anesthesiology, THT 958, University of Alabama at Birmingham, 1900 University Blvd, Birmingham, AL 35233. E-mail Joe.Beckman@ccc.uab.edu


Key Words: peroxynitrite • nitric oxide • nitrosothiol


*    Introduction
 
The actions of nitric oxide (NO) mediating vasorelaxation through activating guanylate cyclase to produce cGMP are now well-established, as recognized by the award of the Nobel prize in 1998. However, the production of NO is also implicated in a much broader range of physiological and pathological actions that are independent of cGMP. Cytokines in particular are known to greatly stimulate NO production as part of the nonspecific immune system and may play a significant role in heart disease. Cytokines are known to induce expression of the inducible nitric oxide synthase (iNOS) in cardiac myocytes, which contributes in part to myocyte contractile dysfunction.

In this issue of Circulation Research, Arstall et al1 demonstrate that iNOS upregulation by interleukin-1ß and interferon-{gamma} increases apoptosis in cultured myocytes by a process that was independent of guanylate cyclase activation and cGMP. Cell death was blocked by both selective and general iNOS inhibitors, clearly implicating the production of NO in cell death. However, concentrations of an NO donor added in similar concentrations to the amount of endogenous nitrite produced by myocytes after cytokine treatment did not stimulate cell death, suggesting that NO itself was not cytotoxic.

The chemical reactivity and toxicity of NO can be greatly increased by its diffusion-limited reaction with superoxide (O2.-) to form peroxynitrite (ONOO-). A role for ONOO- was implicated in myocyte apoptosis by Arstall et al1 by showing that the O2.-and ONOO- scavenger Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP) protected myocytes from cytokine-induced apoptosis. Myocytes were also shown . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
M. Khan, I. K. Mohan, V. K. Kutala, D. Kumbala, and P. Kuppusamy
Cardioprotection by Sulfaphenazole, a Cytochrome P450 Inhibitor: Mitigation of Ischemia-Reperfusion Injury by Scavenging of Reactive Oxygen Species
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 813 - 821.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Ptasinska, S. Wang, J. Zhang, R. A. Wesley, and R. L. Danner
Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway
FASEB J, March 1, 2007; 21(3): 950 - 961.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. Takakura, W. Xiaohong, K. Takeuchi, and S. Fukuda
Peroxynitrite Decreases Dopamine's Vasoconstrictive Activity
Anesth. Analg., November 1, 2003; 97(5): 1492 - 1496.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Uchiyama, H. Otani, T. Okada, T. Uchiyama, H. Ninomiya, M. Kido, H. Imamura, S. Nakao, and K. Shingu
Integrated pharmacological preconditioning in combination with adenosine, a mitochondrial KATP channel opener and a nitric oxide donor
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 148 - 159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Poljakovic and K. Persson
Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide
Am J Physiol Renal Physiol, January 1, 2003; 284(1): F22 - F31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Tian, J. Liu, P. B. Bitterman, and R. J. Bache
Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1958 - H1967.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. C. Wollert, B. Fiedler, S. Gambaryan, A. Smolenski, J. Heineke, E. Butt, C. Trautwein, S. M. Lohmann, and H. Drexler
Gene Transfer of cGMP-Dependent Protein Kinase I Enhances the Antihypertrophic Effects of Nitric Oxide in Cardiomyocytes
Hypertension, January 1, 2002; 39(1): 87 - 92.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. He, Y. Xiao, and L. Zhang
Cocaine-Mediated Apoptosis in Bovine Coronary Artery Endothelial Cells: Role of Nitric Oxide
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 180 - 187.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Ukai, C.-P. Cheng, H. Tachibana, A. Igawa, Z.-S. Zhang, H.-J. Cheng, and W. C. Little
Allopurinol Enhances the Contractile Response to Dobutamine and Exercise in Dogs With Pacing-Induced Heart Failure
Circulation, February 6, 2001; 103(5): 750 - 755.
[Abstract] [Full Text] [PDF]